These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 21043738)

  • 1. Antiplatelet therapy in the treatment and prevention of vascular disease: some clear answers, some new questions.
    Dunbabin D; Sandercock P; Collaboration AT
    Platelets; 1994; 5(1):3-12. PubMed ID: 21043738
    [No Abstract]   [Full Text] [Related]  

  • 2. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherothrombosis and the role of antiplatelet therapy.
    Steg PG; Dorman SH; Amarenco P
    J Thromb Haemost; 2011 Jul; 9 Suppl 1():325-32. PubMed ID: 21781269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
    BMJ; 1994 Jan; 308(6921):81-106. PubMed ID: 8298418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ
    Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Antiplatelet Trialists' Collaboration.
    Antiplatelet Trialists' Collaboration
    Br Med J (Clin Res Ed); 1988 Jan; 296(6618):320-31. PubMed ID: 3125883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelets in stroke prevention: the MATCH trial. Some answers, many questions and countless perspectives.
    Bezerra DC; Bogousslavsky J
    Cerebrovasc Dis; 2005; 20 Suppl 2():109-18. PubMed ID: 16327260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
    Bianchi C; Montalvo V; Ou HW; Bishop V; Abou-Zamzam AM
    Ann Vasc Surg; 2007 Mar; 21(2):163-6. PubMed ID: 17349357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society guidelines.
    Bell AD; Roussin A; Cartier R; Chan WS; Douketis JD; Gupta A; Kraw ME; Lindsay TF; Love MP; Pannu N; Rabasa-Lhoret R; Shuaib A; Teal P; Théroux P; Turpie AG; Welsh RC; Tanguay JF;
    Can J Cardiol; 2011; 27 Suppl A():S1-59. PubMed ID: 21640290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial.
    Wang TH; Bhatt DL; Fox KA; Steinhubl SR; Brennan DM; Hacke W; Mak KH; Pearson TA; Boden WE; Steg PG; Flather MD; Montalescot G; Topol EJ;
    Eur Heart J; 2007 Sep; 28(18):2200-7. PubMed ID: 17673448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of antiplatelet therapy in the outpatient setting: Canadian Cardiovascular Society Guidelines Executive Summary.
    Bell AD; Roussin A; Cartier R; Chan WS; Douketis JD; Gupta A; Kraw ME; Lindsay TF; Love MP; Pannu N; Rabasa-Lhoret R; Shuaib A; Teal P; Théroux P; Turpie AG; Welsh RC; Tanguay JF
    Can J Cardiol; 2011; 27(2):208-21. PubMed ID: 21459270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination antiplatelet therapy in patients with peripheral arterial disease: is the best therapy aspirin, clopidogrel, or both?
    Mohler ER
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S1-6. PubMed ID: 19213065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of antiplatelet therapy across the spectrum of patients with coronary artery disease.
    Bhatt DL
    Am J Cardiol; 2009 Feb; 103(3 Suppl):11A-19A. PubMed ID: 19166708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of efficacy and safety of antiplatelet therapy in cardiovascular and cerebrovascular disease.
    Gebel JM
    Am J Cardiovasc Drugs; 2010; 10(2):115-24. PubMed ID: 20334449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigational antiplatelet drugs for the treatment and prevention of coronary artery disease.
    Zeidner JF; Frishman WH; Lerner RG
    Cardiol Rev; 2008; 16(5):250-9. PubMed ID: 18708826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease.
    ; Anand S; Yusuf S; Xie C; Pogue J; Eikelboom J; Budaj A; Sussex B; Liu L; Guzman R; Cina C; Crowell R; Keltai M; Gosselin G
    N Engl J Med; 2007 Jul; 357(3):217-27. PubMed ID: 17634457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet and antithrombotic treatment of patients with peripheral arterial disease.
    Poredos P; Jezovnik MK
    Int Angiol; 2010 Feb; 29(1):20-6. PubMed ID: 20224527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular gene therapy in the 21st century.
    Clowes AW
    Thromb Haemost; 1997 Jul; 78(1):605-10. PubMed ID: 9198224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.
    Hsu PI
    J Gastroenterol Hepatol; 2012 Apr; 27(4):654-61. PubMed ID: 22283743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of antiplatelet therapy for secondary stroke prevention.
    Malinina D; Zema C; Sander S; Serebruany V
    Expert Rev Pharmacoecon Outcomes Res; 2007 Aug; 7(4):357-63. PubMed ID: 20528418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.